Billionaire hedge fund manager Ken Griffin just raised Citadel's position in global-consulting powerhouse Accenture.
Jeff Yass and Ken Griffin are in a league of their own. Yass is the co-founder and managing director at the global ...
A highly anticipated obesity-drug candidate from biotech Amgen helped patients shed a significant amount of weight in a midstage study. Subjects taking Amgen’s MariTide lost 20% of their body weight ...
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a ...
Wall Street witnessed a historic day with the S&P 500 and Dow Jones Industrial Average reaching record highs. The Russell ...
Her comments, made during a session released last Friday, comes at a time when the market is experiencing increased ...
Sl Green sold a stake last week in One Vanderbilt, its trophy office tower near Grand Central Terminal that’s fully leased, ...
Billionaires' Row is a collection of luxury condominiums in New York City, located below Central Park. According to the study ...
It’s the ultimate Christmas gift for fans of Jurassic Park,and should even fit snugly in the living room - as long as the €6m price tag is no object. A rare baby allosaurus dinosaur fossil, which ...
In a year that has flown by, the Palmetto Bowl is upon us as the (8-3) South Carolina Gamecocks go on the road to take on the ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today issued the following statement: ...
(Reuters) - U.S. stock index futures were flat on Tuesday, as investors paused following several sessions of gains and ...